RecallDepth
Class II Terminated

Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-0106-01

Company
Pfizer Inc.
Recall Initiated
September 19, 2018
Posted
October 10, 2018
Recall Number
D-0005-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,416 vials
Firm Location
New York, NY, United States

Reason for Recall

Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Distribution

U.S.A. nationwide. The following countries received product from Lot S91616: Albania, South Africa, Israel, Afghanistan, Rwanda, Botswana, Zimbabwe and Iraq as part of the Compassionate Use Program.

Lot / Code Info

Lot S91616

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls